Delivery Order SPE2DB20D2002-SPE2DB22FL55Q
- Not listed
- This federal contract award is for the delivery of 4555888869 units of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,547.24 firm-fixed-price contract was awarded on January 10, 2022 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,934 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 23, 2024, with a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals to the Defense Logistics Agency (DLA). The $7,046.64 delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through September 23, 2022 and is a firm fixed-price delivery order. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $10,754.36 for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The contract, placed by the Defense Logistics Agency (DLA), has an ultimate completion date of August 7, 2024 and a firm fixed price pricing structure. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $97,345.00 firm fixed-price delivery order contract has a completion date of July 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and is an individual delivery order under Amerisourcebergen's $999,999,999.00 Indefinite...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,486.46 delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 18, 2024, with a completion date of July 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $9,532.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA). The $22,780.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 16, 2024 with a completion date of May 17, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS to the Defense Logistics Agency (DLA). The $3,281.82 firm fixed price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,174.44 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 28, 2022, with a completion date of December 29, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL55QDelivery Order
This federal contract award is for the delivery of HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $5,738.23 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 20, 2022, with a completion date of July 21, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to support military healthcare programs globally. This particular delivery order did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/20/22 |